Latest News Feed

Inolife R&D Signs LOI With ADW Diabetes to Make Its Inojex Needle-Free Injector Available to Diabetics in USA
Inolife R&D Announces the Commencement of Its Public Listing Process to Meet Growing Demand for Its Needle-Free Injection Technologies.